UAB "TBS Pharma" Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 1,758,954 |
| 293,159 |
| 138,775 |
| 117,536 |
| 19,589 |
| 18.76 |
| 6.68 |
| 271,240 |
| 547,237 |
| 15,124 |
| 803,353 |
| 2024 |
|---|
| 1,589,674 |
| 293,298 |
| 94,243 |
| 80,065 |
| 14,772 |
| 18.79 |
| 5.04 |
| 351,305 |
| 650,120 |
| 9,983 |
| 991,442 |
| 2025 |
|---|
| 1,420,173 |
| 254,511 |
| 41,060 |
| 28,098 |
| 5,035 |
| 19.16 |
| 1.98 |
| 379,403 |
| 406,017 |
| 7,451 |
| 777,969 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 1,420,173 |
| 254,511 |
| 41,060 |
| 28,098 |
| 5,035 |
| 19.16 |
| 1.98 |
| 379,403 |
| 406,017 |
| 7,451 |
| 777,969 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
1,420,173 €-11 % *
Sales per employee (€)
254,511 €-13 % *
Profit before tax (€)
41,060 €-56 % *
Net Profit (€)
28,098 €-65 % *
Profit per employee (€)
5,035 €-66 % *
Total profitability (%)
19.16 %1.97 % *
Net profitability (%)
1.98 %-60.71 % *
Equity (€)
379,403 €8 % *
Amounts Payable And Liabilities (€)
406,017 €-38 % *
Non-current Assets (€)
7,451 €-25 % *
CurrentAssets (€)
777,969 €-22 % *
